CZ Veterinaria and Bioingenium collaborate in the development of new vaccines Blog Post

Bioingenium, a biotech service company based at the Barcelona Science Park (PCB), and the Galician biopharmaceutical company CZ Veterinaria announce their collaboration in the development of new generation vaccines. CZ Veterinary will invest in a new project where Bioingenium technology is used for the production of recombinant vaccines of new generation, able to improve the protection of animals against diseases. The project started in 2016 and now this new vaccine has successfully passed the first tests in experimental stages.

 

Genome sequencing reveals ancient interbreeding between chimpanzees and bonobos Blog Post

A study led by Tomàs Marquès-Bonet, ICREA researcher at the Centro Nacional de Analisis Genomico (CNAG-CRG) –based at the Barcelona Science Park– and the Institute of Evolutionary Biology (IBE) – joint centre of the Spanish National Research Council (CSIC) and the Pompeu Fabra University (UPF)–  together with Christina Hvilsom, researcher at the Copenhagen Zoo, reveals ancient admixture events among the extant species closest to humans: bonobos and chimpanzees. The work is published today in Science.

 

IBEC has been designated one of five EU Centers of Excellence in Health in new EC report Blog Post

The Institute for Bioengineering of Catalonia (IBEC) has been designated one of five European Centres of Excellence (CoE) in Health in a report by the European Commission’s Directorate-General for Research & Innovation on European Union international positioning. The other European organizations named as Health CoEs are: CEA Tech- Leti (Grenoble, France); the Trinity College Dublin (Germany); el King’s College London (United Kingdom) and the Erasmus University Medical Centre Rotterdam (Belgium, Netherlands).

 

Midas Clean launches Baula, a family of effervescent tablets that start the 3.0 era in the ‘cleaning’ field Blog Post

Under the name Baula, the start-up Midas Clean, based at the Barcelona Science Park, has launched to market a new family of effervescent tablets that mark the start of the 3.0 era in the cleaning sector by combining efficacy (1.0) with ecology (2.0). These are ‘first in class’ –products developed by means of a highly innovative processing technology and under social, economical and environmental sustainability criteria– thereby offering an equal or superior performance to that of high-end equivalent proposal based on a non-ecological formulation. 

 

Bioinformatics Mind the Byte enters the Japanese market Blog Post

Mind the Byte, a bioinformatics computational design company dedicated to pharmaceuticals products through big data and machine learning, has signed a distribution agreement with the Japanese company Filgen to access the bioinformatics market in Japan. Located at Parc Científic of Barcelona, the company expects to reach a turnover of 1.2 million Euros in 2020 in this country, a market it had no commercial presence until now.

 

The Barcelona Science Park hosts a bilateral meeting between Scandinavian and Spanish EIT Health partners Blog Post

More than 60 people from 42 different EIT Health partners and third parties from Spain and Scandinavia met last week in Barcelona at the bilateral meeting, organized by these two regional CLCs. This is the second bilateral event organized in Barcelona, the first one took place last June and the invited CLC was the French one. EIT Health has nodes in Spain, France, Uk-Ireland, Belgium-Netherlands, Sweden and Scandinavia. EIT Health Spain, based at the Barcelona Science Park (PCB), is made up of 18 organizations: companies, universities, research centers, hospitals and technology centers. 

 

Stat-Diagnostica attracts Siemens Venture Capital as a new investor Blog Post

Medical diagnostics company Stat-Diagnostica, based at the Barcelona Science Park, has closed an extension of its Series C financing with Siemens Venture Capital. Led by Gilde Healthcare, the Series C financing round also drew participation from existing investors, including Kurma Partners, Ysios Capital, Idinvest Partners, Boehringer Ingelheim Venture Fund, Caixa Capital Risc, and Axis. The additional proceeds will be used to support the 2017 European launch of its DiagCORE Near Patient Testing system. 

 

Health & Bio Team Dating: Bringing together entrepreneurs and life science projects Blog Post

On 1 December at La Dama del Paraigües (Parc de la Ciutadella, Barcelona), Biocat and CataloniaBio – based at the Barcelona Science Park– are holding with Banc Sabadell once again Barcelona Health & Bio Team Dating, an event to help develop a bioentrepreneurial ecosystem and act as a catalyst for new business projects. This meeting between scientists and research groups working in life sciences and business people aims to bring together groups who can create new business synergies and start ups.  

 

Researchers identify a key molecule in psoriasis development Blog Post

A study published in Journal of Investigative Dermatology has identified a potential therapeutic target for the treatment of psoriasis. The work shows that the TREX2 gene has a relevant role in the inflammatory response that develops during the illness. The research –led by researchers from the Department of Pathology and Experimental Therapeutics of the Faculty of Medicine and Health Sciences of the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL)–  counts with the participation of experts from the Scientific and Technologic Centers of the UB (CCiTUB) based at the Barcelona Science Park (PCB).